J.P. Morgan Life Sciences Private Capital Closes Inaugural Biotechnology Venture Capital Fund With Over $500 Million in Commitments
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.